Compound Detail
CHEMBL285802
ZOTEPINE 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL285802 |
| Name | ZOTEPINE |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | HDOZVRUNCMBHFH-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
12
Targets
20
Activities
2
Assay Types
0
PK Parameters
20
Publications
8
Known Names
1
Indications
Molecular Properties
331.9
MW (Da)
4.88
ALogP
3
HBA
0
HBD
12.5
PSA (Ų)
0.79
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Indications
Psychotic Disorders
ATC Classification
N05AX11
zotepine
Level 1: NERVOUS SYSTEM
Level 2: PSYCHOLEPTICS
Activity Summary
Ki 19 meas. best 9.3
IC50 1 meas. best 6.22
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| 5-hydroxytryptamine receptor 2A CHEMBL224 | Ki | 9.3 | 8.97 | 0.5 | 3 |
| Histamine H1 receptor CHEMBL231 | Ki | 9.21 | 8.84 | 0.6 | 2 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | Ki | 8.54 | 8.54 | 2.9 | 1 |
| Adrenergic receptor alpha-1 CHEMBL2094251 | Ki | 8.47 | 8.47 | 3.4 | 1 |
| D(3) dopamine receptor CHEMBL234 | Ki | 8.19 | 7.995 | 6.4 | 2 |
| D(2) dopamine receptor CHEMBL217 | Ki | 7.96 | 7.925 | 11.0 | 2 |
| D(1A) dopamine receptor CHEMBL2056 | Ki | 7.54 | 7.31 | 29.0 | 2 |
| D(4) dopamine receptor CHEMBL219 | Ki | 7.41 | 7.41 | 39.0 | 2 |
| Adrenergic receptor alpha-2 CHEMBL2095158 | Ki | 6.75 | 6.385 | 180.0 | 2 |
| 5-hydroxytryptamine receptor 1A CHEMBL214 | Ki | 6.48 | 6.48 | 330.0 | 1 |
| Muscarinic acetylcholine receptor M4 CHEMBL1821 | Ki | 6.26 | 6.26 | 550.0 | 1 |
| Histone deacetylase 6 CHEMBL1865 | IC50 | 6.22 | 6.22 | 602.4 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 15646539 | 10.1016/s0399-8320(04)95062-2 | Unchecked | 11 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | NON-PROTEIN TARGET | 8 |
| 37468498 | 10.1038/s41467-023-40064-9 | Thromboxane A2 receptor | 5 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 4 |
| 37468498 | 10.1038/s41467-023-40064-9 | D(1A) dopamine receptor | 4 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 4 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2B | 4 |
| 37468498 | 10.1038/s41467-023-40064-9 | Progesterone receptor | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Prostaglandin G/H synthase 1 | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2A | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Glucocorticoid receptor | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M2 | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Nuclear receptor subfamily 1 group I member 2 | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Gamma-aminobutyric acid receptor subunit alpha-1 | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Estrogen receptor | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 1A | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Mu-type opioid receptor | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Sodium-dependent serotonin transporter | 2 |
Data from ChEMBL 36 via Core Engine